Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992701 | PMC |
| http://dx.doi.org/10.5021/ad.2019.31.1.103 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Case Report of Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Pulmonary Fibrosis.
Ann Dermatol
April 2022
Department of Dermatology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and lethal lung disease characterized by progressive dyspnea and irreversible loss of lung function. Pirfenidone is a novel anti-fibrotic and anti-inflammatory drug, which reduces deterioration in the lung function and prolongs progression-free survival in patients with IPF. However, it has adverse effects including gastrointestinal symptoms, hepatic dysfunction or skin photosensitivity, and rash.
View Article and Find Full Text PDFPirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Lung Fibrosis.
Ann Dermatol
February 2019
Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!